100
Participants
Start Date
January 31, 2004
Primary Completion Date
July 31, 2005
Study Completion Date
October 31, 2009
Express™ Renal Premounted Stent System
"This device is indicated for use as an adjunct to percutaneous transluminal renal angioplasty (PTRA) of a:~* Single, de novo or restenotic (from PTRA) atherosclerotic lesion in the ostium of the renal artery~* Lesion length ≤15mm~* Lesion involving the aortorenal ostium or the leading edge of the stenosis is located within 5 mm of the opacified aortic lumen~* RVD 4.0-7.0mm"
NYPH & Trustees of Columbia University of New York, New York
Philadelphia Health and Education Corp. d/b/a Drexel University College of Medicine, Philadelphia
CAMC Institute, Charleston
WakeMed, Raleigh
Greenville Hospital System, Greenville
Sarasota Memorial Hospital Care System, Sarasota
St. Vincent Hospital & Health Care Center, Inc., Indianapolis
The Care Group, LLC, Indianapolis
North Central Heart Institute, Sioux Falls
Peoria Radiology Associates Research & Education Foundation, Peoria
Prairie Education & Research Cooperative, Springfield
Ochsner Clinic Foundation, New Orleans
Cardiovascular Institute of the South (CIS), Lafayette
St. Luke's Episcopal Hospital, Houston
Lead Sponsor
Boston Scientific Corporation
INDUSTRY